共 59 条
[4]
Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction
[J].
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY,
2007, 292 (02)
:H1120-H1128
[7]
Barbera J A, 2000, Monaldi Arch Chest Dis, V55, P445
[8]
Bozinovski Steven, 2006, Int J Chron Obstruct Pulmon Dis, V1, P31, DOI 10.2147/copd.2006.1.1.31